The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation-1

Emistry, at the end of the time course. Phosphorylation of Akt at Ser473 was found to be reduced under PI3K inhibition with LY294002 (10 μM). Black arrows show cells expressing phosphorylated Akt. (B) The difference between the length of the tibiae in the beginning and at the end of the time course represents the bone growth and it was found to be significantly reduced in bones treated with LY294002 (45% reduction) or PI3-K α inhibitor IV (500 nM) (35% reduction) compared to DMSO. (C) At the end of culture period the tibiae were also stained with Alcian blue/Alizarin red. We notice decreased length of both proximal (gp1) and distal (gp2) growth plates of tibiae treated with LY294002 or PI3-K α inhibitor IV. (D) Measurements of the growth plates and mineralized area (min) length confirmed the reduction of these under PI3K inhibition with LY294002. (E) When the gp1, gp2 and min were expressed as ratio of the entire bone length there is an increased ratio of the mineralized area in the LY294002 treated tibiae.<p><b>Copyright information:</b></p><p>Taken from "The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation"</p><p>http://www.biomedcentral.com/1471-213X/8/40</p><p>BMC Developmental Biology 2008;8():40-40.</p><p>Published online 11 Apr 2008</p><p>PMCID:PMC2329617.</p><p>